University of New Mexico:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of New Mexico - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11521
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of New Mexico (UNM) is an educational service provider that offers bachelors, masters, doctoral and professional degree programs in various fields. The university offers programs such as evening and weekend degree programs, continuing education, extended learning, Latin American studies and others. It also conducts research studies in fields of intellectual property, technology transfer, and health science. UNM operates a health science center that offers emergency and trauma cares. The university operates through its colleges such as school of management, college of arts and sciences, college of education, school of engineering, college of fine arts, and health sciences center, among others. UNM is headquartered in Albuquerque, New Mexico, the US.

University of New Mexico – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of New Mexico, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of New Mexico, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
University of New Mexico, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
ExoVita Biosciences Enters into Research Agreement with University of New Mexico 10
University Of New Mexico Enters Into Agreement With Biosortia Pharma 11
Licensing Agreements 12
ExoVita Biosciences Enters into Licensing Agreement with University of New Mexico 12
University of New Mexico – Key Competitors 13
University of New Mexico – Key Employees 14
University of New Mexico – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Government and Public Interest 16
Sep 25, 2018: $2.8 million federal grant awarded to TGen-UNM consortium to address diabetic blindness 16
Nov 14, 2017: St. Baldrick’s Foundation Announces $2.2 Million in Grants to Give More Kids Access to Clinical Trials 18
Jul 14, 2017: Biology Professor Receives Funding to Fight Pervasive African Parasite 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
University of New Mexico, Pharmaceuticals & Healthcare, Key Facts 2
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of New Mexico, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of New Mexico, Deals By Therapy Area, 2012 to YTD 2018 8
University of New Mexico, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ExoVita Biosciences Enters into Research Agreement with University of New Mexico 10
University Of New Mexico Enters Into Agreement With Biosortia Pharma 11
ExoVita Biosciences Enters into Licensing Agreement with University of New Mexico 12
University of New Mexico, Key Competitors 13
University of New Mexico, Key Employees 14
University of New Mexico, Subsidiaries 15

List of Figures
University of New Mexico, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of New Mexico, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[University of New Mexico:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Brambles Limited (BXB):企業の財務・戦略的SWOT分析
    Brambles Limited (BXB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Pentax Europe GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Pentax Europe GmbH (Pentax Medical), a subsidiary of Hoya Corp, is a medical device company that offers clinical endo-imaging solutions. The company provides products in the therapeutic areas of gastroenterology, endoscopic ultrasound, ENT and speech, pulmonology and urology, among others. I …
  • PathoQuest SAS-医療機器分野:企業M&A・提携分析
    Summary PathoQuest SAS (PathoQuest) is a biotechnology company that offers game changing metagenomics approach to improve the breadth of pathogen detection. The company offers automated bioinformatics software that provide comprehensive pathogens database to produce microbiome reports. Its testing a …
  • Ratchaburi Electricity Generating Holding Public Co Ltd:発電所・企業SWOT分析
    Ratchaburi Electricity Generating Holding Public Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT an …
  • ET Solar Group Corporation:企業の戦略的SWOT分析
    ET Solar Group Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Medicontur Medical Engineering Ltd:製品パイプライン分析
    Summary Medicontur Medical Engineering Ltd (Medicontur) is a developer and manufacturer of intraocular lenses. The company offers hydrophilic and hydrophobic model lenses including monofocal aspheric, toric, and standard monofocal aspheric lenses; preloaded capsular tension rings; PMMA implants; inj …
  • Empire Electric Association Inc:企業の戦略的SWOT分析
    Empire Electric Association Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Novozymes AS (NZYM B):企業の財務・戦略的SWOT分析
    Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Lannett Company Inc (LCI):企業の財務・戦略的SWOT分析
    Lannett Company Inc (LCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Leroy Seafood Group ASA:企業の戦略・SWOT・財務情報
    Leroy Seafood Group ASA - Strategy, SWOT and Corporate Finance Report Summary Leroy Seafood Group ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • A.P. Eagers Limited:企業の戦略・SWOT・財務情報
    A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report Summary A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • OSE Immunotherapeutics (OSE):製薬・医療:M&Aディール及び事業提携情報
    Summary OSE Immunotherapeutics (OSE), formerly OSE Pharma SA is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The company’s memopi technology is employed in studying the development of treatments for ovarian, colon and …
  • Freeport-McMoRan Inc:戦略・SWOT・企業財務分析
    Freeport-McMoRan Inc - Strategy, SWOT and Corporate Finance Report Summary Freeport-McMoRan Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Western Energy Services Corp (WRG):企業の財務・戦略的SWOT分析
    Summary Western Energy Services Corp (Western) is an oilfield service company that offers contract drilling, well services and oilfield rental equipment services. The company offers services through Horizon Drilling, Eagle Well Servicing and Stoneham Drilling Corporation. It also provides rental ser …
  • UGI Corp (UGI):企業の財務・戦略的SWOT分析
    UGI Corp (UGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Manhattan Scientifics Inc (MHTX):企業の財務・戦略的SWOT分析
    Summary Manhattan Scientifics Inc (Manhattan Scientifics) is a diversified company. The company transfers and commercializes technologies in nanomedicine space. It has acquired technologies in the fields of holographic data storage, alternative energy, water purification, advanced computer haptics a …
  • Wawa Inc:企業の戦略・SWOT・財務分析
    Wawa Inc - Strategy, SWOT and Corporate Finance Report Summary Wawa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • KDDI Corporation (9433):企業の財務・戦略的SWOT分析
    KDDI Corporation (9433) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Alexandria Real Estate Equities Inc:企業のM&A・事業提携・投資動向
    Alexandria Real Estate Equities Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alexandria Real Estate Equities Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Interleukin Genetics Inc (ILIU)-製薬・医療分野:企業M&A・提携分析
    Summary Interleukin Genetics Inc (Interleukin) is a molecular diagnostics company which develops and distributes genetic tests for the personalized health market. Its major genetic tests include ILUSTRA genetic risk test ; cardiovascular risk test; weight management genetic test; bone health genetic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆